61 related articles for article (PubMed ID: 20974589)
1. Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery.
Chan KY; Baun M; de Vries R; van den Bogaerdt AJ; Dirven CM; Danser AH; Jansen-Olesen I; Olesen J; Villalón CM; MaassenVanDenBrink A; Gupta S
Cephalalgia; 2011 Jan; 31(2):181-9. PubMed ID: 20974589
[TBL] [Abstract][Full Text] [Related]
2. Pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide (Part 2): biology and clinical importance in central nervous system and inflammatory disorders.
Moody TW; Jensen RT
Curr Opin Endocrinol Diabetes Obes; 2021 Apr; 28(2):206-213. PubMed ID: 33481421
[TBL] [Abstract][Full Text] [Related]
3. The PACAP receptor: a novel target for migraine treatment.
Schytz HW; Olesen J; Ashina M
Neurotherapeutics; 2010 Apr; 7(2):191-6. PubMed ID: 20430318
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and In Vitro Characterization of Glycopeptide Drug Candidates Related to PACAP
Apostol CR; Tanguturi P; Szabò LZ; Varela D; Gilmartin T; Streicher JM; Polt R
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443519
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of Oral Cancers by Targeting VPAC Receptors: Preliminary Report.
Nerli R; Kalloli M; Rangrez S; Ghagane SC; Vinchurkar K; Chandra S; Thakur ML
Asian Pac J Cancer Prev; 2023 May; 24(5):1711-1715. PubMed ID: 37247292
[TBL] [Abstract][Full Text] [Related]
6. The functional heterogeneity of PACAP: Stress, learning, and pathology.
Rajbhandari AK; Barson JR; Gilmartin MR; Hammack SE; Chen BK
Neurobiol Learn Mem; 2023 Sep; 203():107792. PubMed ID: 37369343
[TBL] [Abstract][Full Text] [Related]
7. Shared and independent roles of CGRP and PACAP in migraine pathophysiology.
Kuburas A; Russo AF
J Headache Pain; 2023 Apr; 24(1):34. PubMed ID: 37009867
[TBL] [Abstract][Full Text] [Related]
8. PACAP signaling is not involved in GTN- and levcromakalim-induced hypersensitivity in mouse models of migraine.
Guo S; Ernstsen C; Hay-Schmidt A; Kristensen DM; Ashina M; Olesen J; Christensen SL
J Headache Pain; 2022 Dec; 23(1):155. PubMed ID: 36471250
[TBL] [Abstract][Full Text] [Related]
9. Localization of the neuropeptides pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal peptide, and their receptors in the basal brain blood vessels and trigeminal ganglion of the mouse CNS; an immunohistochemical study.
Lund AM; Hannibal J
Front Neuroanat; 2022; 16():991403. PubMed ID: 36387999
[TBL] [Abstract][Full Text] [Related]
10. Calcitonin Gene-Related Peptide (CGRP) and Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in Migraine Pathogenesis.
Christensen CE; Ashina M; Amin FM
Pharmaceuticals (Basel); 2022 Sep; 15(10):. PubMed ID: 36297301
[TBL] [Abstract][Full Text] [Related]
11. Plasma Levels of CGRP During a 2-h Infusion of VIP in Healthy Volunteers and Patients With Migraine: An Exploratory Study.
Pellesi L; Al-Karagholi MA; De Icco R; Chaudhry BA; Lopez CL; Snellman J; Hannibal J; Amin FM; Ashina M
Front Neurol; 2022; 13():871176. PubMed ID: 35432170
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptides and the Nodes of Ranvier in Cranial Headaches.
Edvinsson JCA; Haanes KA; Edvinsson L
Front Physiol; 2021; 12():820037. PubMed ID: 35095575
[TBL] [Abstract][Full Text] [Related]
13. Effect of Vasoactive Intestinal Polypeptide on Development of Migraine Headaches: A Randomized Clinical Trial.
Pellesi L; Al-Karagholi MA; De Icco R; Coskun H; Elbahi FA; Lopez-Lopez C; Snellman J; Hannibal J; Amin FM; Ashina M
JAMA Netw Open; 2021 Aug; 4(8):e2118543. PubMed ID: 34357396
[TBL] [Abstract][Full Text] [Related]
14. PAC1 receptor blockade reduces central nociceptive activity: new approach for primary headache?
Hoffmann J; Miller S; Martins-Oliveira M; Akerman S; Supronsinchai W; Sun H; Shi L; Wang J; Zhu D; Lehto S; Liu H; Yin R; Moyer BD; Xu C; Goadsby PJ
Pain; 2020 Jul; 161(7):1670-1681. PubMed ID: 32142016
[TBL] [Abstract][Full Text] [Related]
15. Pituitary Adenylate Cyclase-Activating Polypeptide: 30 Years in Research Spotlight and 600 Million Years in Service.
Denes V; Geck P; Mester A; Gabriel R
J Clin Med; 2019 Sep; 8(9):. PubMed ID: 31540472
[TBL] [Abstract][Full Text] [Related]
16. Characterization of binding, functional activity, and contractile responses of the selective 5-HT
Rubio-Beltrán E; Labastida-Ramírez A; Haanes KA; van den Bogaerdt A; Bogers AJJC; Zanelli E; Meeus L; Danser AHJ; Gralinski MR; Senese PB; Johnson KW; Kovalchin J; Villalón CM; MaassenVanDenBrink A
Br J Pharmacol; 2019 Dec; 176(24):4681-4695. PubMed ID: 31418454
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiological Mechanisms in Migraine and the Identification of New Therapeutic Targets.
Haanes KA; Edvinsson L
CNS Drugs; 2019 Jun; 33(6):525-537. PubMed ID: 30989485
[TBL] [Abstract][Full Text] [Related]
18. Dynamic changes in CGRP, PACAP, and PACAP receptors in the trigeminovascular system of a novel repetitive electrical stimulation rat model: Relevant to migraine.
Zhang Q; Han X; Wu H; Zhang M; Hu G; Dong Z; Yu S
Mol Pain; 2019; 15():1744806918820452. PubMed ID: 30799680
[TBL] [Abstract][Full Text] [Related]
19. Migraine-provoking substances evoke periorbital allodynia in mice.
De Logu F; Landini L; Janal MN; Li Puma S; De Cesaris F; Geppetti P; Nassini R
J Headache Pain; 2019 Feb; 20(1):18. PubMed ID: 30764776
[TBL] [Abstract][Full Text] [Related]
20. VPAC1 receptors play a dominant role in PACAP-induced vasorelaxation in female mice.
Ivic I; Balasko M; Fulop BD; Hashimoto H; Toth G; Tamas A; Juhasz T; Koller A; Reglodi D; Solymár M
PLoS One; 2019; 14(1):e0211433. PubMed ID: 30682157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
